Effect of guanylate cyclase-C activity on energy and glucose homeostasis

Academic Article


  • © 2014 by the American Diabetes Association. Uroguanylin is a gastrointestinal hormone primarily involved in fluid and electrolyte handling. It has recently been reported that prouroguanylin, secreted postprandially, is converted to uroguanylin in the brain and activates the receptor guanylate cyclase-C (GC-C) to reduce food intake and prevent obesity.We tested central nervous system administration of two GC-C agonists and found no significant reduction of food intake. We also carefully phenotyped mice lacking the GC-C receptor and found them to have normal body weight, adiposity, and glucose tolerance. Interestingly, uroguanylin knockout mice had a small but significant increase in body weight and adiposity that was accompanied by glucose intolerance. Our data indicate that the modest effects of uroguanylin on energy and glucose homeostasis are not mediated by central GC-C receptors.
  • Published In

  • Diabetes  Journal
  • Digital Object Identifier (doi)

    Author List

  • Begg DP; Steinbrecher KA; Mul JD; Chambers AP; Kohli R; Haller A; Cohen MB; Woods SC; Seeley RJ
  • Start Page

  • 3798
  • End Page

  • 3804
  • Volume

  • 63
  • Issue

  • 11